Glycogen storage disease type I: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
'''For the main page on glycogen storage disease, please click [[Glycogen storage disease|here]]'''<br> | '''For the main page on glycogen storage disease, please click [[Glycogen storage disease|here]]'''<br> | ||
'''For patient information click [[Glycogen storage disease type I (patient information)|here]]''' | '''For patient information click [[Glycogen storage disease type I (patient information)|here]]''' | ||
{{Glycogen storage disease type I}} | {{Glycogen storage disease type I}} | ||
{{CMG}}; {{AE}}{{Anmol}} | {{CMG}}; {{AE}}{{Anmol}} |
Revision as of 18:03, 31 January 2018
For the main page on glycogen storage disease, please click here
For patient information click here
Glycogen storage disease type I Microchapters |
Differentiating Glycogen storage disease type I from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Glycogen storage disease type I On the Web |
American Roentgen Ray Society Images of Glycogen storage disease type I |
Directions to Hospitals Treating Glycogen storage disease type I |
Risk calculators and risk factors for Glycogen storage disease type I |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Synonyms and keywords: Glucose-6-phosphatase deficiency; Glycogen storage disease type 1; Glycogenosis type 1; Von Gierke's disease; GSD 1; GSD type 1; Hepatorenal form of GSD; Hepatorenal glycogenosis.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Glycogen storage disease type I from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostoc Study of Choice|History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies